Expanded Access Use of Itacitinib to Treat a Single Patient With STAT1 Gain of Function (GOF) Disease

NCT05561985 · clinicaltrials.gov ↗

AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

STAT1 Gain-of-Function Disease

Interventions

DRUG: Itacitinib

Sponsor

Incyte Corporation